Literature DB >> 17657606

Deciphering the molecular basis of breast cancer metastasis with mouse models.

Ann E Vernon1, Suzanne J Bakewell, Lewis A Chodosh.   

Abstract

Breast cancer begins as a localized disease, but has the potential to spread to distant sites within the body. This process--known as metastasis--is the leading cause of death from breast cancer. Whether the ability of cancer cells to metastasize is an intrinsic or acquired feature is currently a topic of considerable debate. Nevertheless, the key cellular events required for metastasis are generally accepted. These include invasion of the surrounding stromal tissue, intravasation, evasion of programmed cell death, arrest within the vasculature at a distant site, extravasation, and establishment and growth within a new microenvironment. The development of mouse models that faithfully mimic critical aspects of human neoplasia has been instrumental in framing our current understanding of multistage carcinogenesis. This review examines the advantages and limitations of existing murine models for mammary carcinogenesis for probing the molecular mechanisms that contribute to metastasis, as well as non-invasive tumor imaging approaches to facilitate these investigations.

Entities:  

Mesh:

Year:  2007        PMID: 17657606     DOI: 10.1007/s11154-007-9041-5

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  208 in total

Review 1.  Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.

Authors:  P Vajkoczy; A Ullrich; M D Menger
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

Review 3.  The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.

Authors:  M D Sternlicht; M J Bissell; Z Werb
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

4.  Involvement of insulin receptor substrate 2 in mammary tumor metastasis.

Authors:  Julie A Nagle; Zhefu Ma; Maura A Byrne; Morris F White; Leslie M Shaw
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

5.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

Review 6.  Proteases and metastasis: clinical relevance nowadays?

Authors:  Julie Decock; Robert Paridaens; Tanja Cufer
Journal:  Curr Opin Oncol       Date:  2005-11       Impact factor: 3.645

Review 7.  The urokinase plasminogen activator system as a target for prognostic studies in breast cancer.

Authors:  R W Stephens; N Brünner; F Jänicke; M Schmitt
Journal:  Breast Cancer Res Treat       Date:  1998       Impact factor: 4.872

8.  RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

Authors:  Anne Hakem; Otto Sanchez-Sweatman; Annick You-Ten; Gordon Duncan; Andrew Wakeham; Rama Khokha; Tak W Mak
Journal:  Genes Dev       Date:  2005-08-17       Impact factor: 11.361

9.  Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.

Authors:  Maralice E Conacci-Sorrell; Tamar Ben-Yedidia; Michael Shtutman; Elena Feinstein; Paz Einat; Avri Ben-Ze'ev
Journal:  Genes Dev       Date:  2002-08-15       Impact factor: 11.361

10.  Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo.

Authors:  J Xu; D Rodriguez; E Petitclerc; J J Kim; M Hangai; Y S Moon; G E Davis; P C Brooks; S M Yuen
Journal:  J Cell Biol       Date:  2001-09-03       Impact factor: 10.539

View more
  13 in total

1.  Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model.

Authors:  Lili Bao; Aliyya Haque; Kamilah Jackson; Sidhartha Hazari; Krzysztof Moroz; Rachna Jetly; Srikanta Dash
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  α2 integrin as regulator of metastatic potential.

Authors:  Miroslav Barancik; Albert Breier
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

Review 3.  How can grafted breast cancer models be optimized?

Authors:  Séverine Mollard; Yoanne Mousseau; Yasser Baaj; Laurence Richard; Jeanne Cook-Moreau; Jacques Monteil; Benoît Funalot; Franck G Sturtz
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

Review 4.  Breast tumor microenvironment: proteomics highlights the treatments targeting secretome.

Authors:  Shui-Tein Chen; Tai-Long Pan; Hsueh-Fen Juan; Tai-Yuan Chen; Yih-Shyan Lin; Chun-Ming Huang
Journal:  J Proteome Res       Date:  2008-02-22       Impact factor: 4.466

5.  DEAD-box helicase DP103 defines metastatic potential of human breast cancers.

Authors:  Eun Myoung Shin; Hui Sin Hay; Moon Hee Lee; Jen Nee Goh; Tuan Zea Tan; Yin Ping Sen; See Wee Lim; Einas M Yousef; Hooi Tin Ong; Aye Aye Thike; Xiangjun Kong; Zhengsheng Wu; Earnest Mendoz; Wei Sun; Manuel Salto-Tellez; Chwee Teck Lim; Peter E Lobie; Yoon Pin Lim; Celestial T Yap; Qi Zeng; Gautam Sethi; Martin B Lee; Patrick Tan; Boon Cher Goh; Lance D Miller; Jean Paul Thiery; Tao Zhu; Louis Gaboury; Puay Hoon Tan; Kam Man Hui; George Wai-Cheong Yip; Shigeki Miyamoto; Alan Prem Kumar; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

Review 6.  Breast cancer metastasis: issues for the personalization of its prevention and treatment.

Authors:  Natascia Marino; Stephan Woditschka; L Tiffany Reed; Joji Nakayama; Musa Mayer; Maria Wetzel; Patricia S Steeg
Journal:  Am J Pathol       Date:  2013-07-26       Impact factor: 4.307

7.  Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.

Authors:  James Finlay; Cai M Roberts; Juyao Dong; Jeffrey I Zink; Fuyuhiko Tamanoi; Carlotta A Glackin
Journal:  Nanomedicine       Date:  2015-06-24       Impact factor: 5.307

8.  Imagable 4T1 model for the study of late stage breast cancer.

Authors:  Kai Tao; Min Fang; Joseph Alroy; G Gary Sahagian
Journal:  BMC Cancer       Date:  2008-08-09       Impact factor: 4.430

9.  BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.

Authors:  M J Hoenerhoff; I Chu; D Barkan; Z-y Liu; S Datta; G P Dimri; J E Green
Journal:  Oncogene       Date:  2009-06-22       Impact factor: 9.867

10.  MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.

Authors:  Xiaofeng Chen; Jinrong Qiu; Dapeng Yang; Jianlei Lu; Caiyun Yan; Xiaoming Zha; Yongmei Yin
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.